DRKS00023561招募中不适用
Covid19 Antibody prevalence and sustainability. A retrospective longitudinal monocentered observational study in Covid 19 PCR positive hospitalworkers.
Ernst von Bergmann Klinikum Potsdam0 个研究点目标入组 207 人开始时间: 2020年11月13日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 207
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 17 Years 至 67 Years（—）
- 性别
- All
入选标准
- •Ernst von Bergmann staff. Conducted Covid 19 PCR test(s). Especially positive Covid 19 PCR positive tests.
排除标准
- •no Covid 19 PCR test conducted
研究者
相似试验
招募中
不适用
Herd immunity level to COVID-19 as an indicator of the epidemic progression in Thailandscreening interventionsHerd immunityepidemic progressionCOVID-19TCTR20200822003HRH Princess Chulabhorn College of Medical Science, chulabhorn royal academy15,000
已完成
不适用
Antibody assesement for COVID-19 prevalence two months after outbreak in the hot spot Region of Tirschenreuth / Bavaria07.1, suspicion of COVID-19J12.8B97.2Other viral pneumoniaCoronavirus as the cause of diseases classified to other chaptersDRKS00021813Kliniken Nordoberpfalz AG2,867
尚未招募
不适用
Post-Coronavirus Disease 2019 (COVID-19) Antibody levels in End-Stage Renal Disease (ESRD) patientsEnd-stage renal disease patients with renal replacement therapy recovered from COVID-19End stage kidney diseaseCOVID-19SARS-CoV-2Post COVID-19RRTRenal replacement therapyESRDTCTR20211005004Bamrasnaradura Infectious Diseases Institute50
尚未招募
不适用
Antibodies to COVID vaccineCTRI/2021/02/031123Kolkata Gastroenterologists association
尚未招募
不适用
Seroprevalence of COVID-19 antibodies among patients living with hemophilia.CTRI/2022/06/043017Maulana Azad Medical College